Integrated Ayurvedic and Allopathy Module of Management in Avaranajanya Madhumeha with Vibanda: Type II Diabetes with Metabolic Syndrome and Chronic Constipation
Case report, Integrated management, Madhumeha, Metabolic syndrome, Sthula pramehi, Type II diabetes,Avarana
Citation Information :
Integrated Ayurvedic and Allopathy Module of Management in Avaranajanya Madhumeha with Vibanda: Type II Diabetes with Metabolic Syndrome and Chronic Constipation. J Res Ayurvedic Sci 2017; 1 (4):296-302.
Rationale: This case illustrates the therapeutic potential of the Ayurvedic mode of management in a chronic type II diabetes mellitus (T2DM) patient with metabolic syndrome (MetS), where conventional treatment is unable to sustain the desired effects. It also tries to observe clinical reporting of any adverse drug interactions between Ayurveda and allopathy systems of medication.
Background: A 55-year-old Indian male presented in May 2017 with complaints of poor glycemic control, despite taking oral hypoglycemic medication, hypertriglyceridemia, and chronic constipation with fullness of stomach, gas, and abdominal bloating. Patient was diabetic for the past 10 years, and constipation history is more than 20 years. He also presented with a history of hypertension for the past 2½ years and hypertriglyceridemia for the past 1 year.
Intervention and outcome: After appropriate analysis of the patient based on Ayurvedic parameters, the patient was treated with a combination of medications along with his current allopathy medication. Lifestyle modification was also advised accordingly. By addressing the underlying cause of imbalance, his gastrointestinal tract (GIT) symptoms decreased, laboratory parameters of blood sugar and triglycerides showed improvement with better regulation and increased quality-of-life. No clinical adverse drug interactions were reported.
Available from: www.diabetesatlas.org (accessed November 21, 2017).
Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J Diabetes 2012 Jun;3:110-117.
Ramachandran A, Chamukuttan S, Shetty SA, Arun N, Susairaj P. Obesity in Asia—is it different from rest of the world. Diabetes Metab Res Rev 2012 Dec;28(Suppl 2):47-51.
Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014;2014:Article ID 943162, 21p.
Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009 Oct;120(16):1640-1645.
Alberti KGMM, Zimmet P. The metabolic syndrome—a new worldwide definition. Lancet 2005 Sep;366(9491):1059-1062.
Olijhoek JK, Van Der Graaf Y, Banga J-D, Algra A, Rabelink TJ, Visseren FLJ. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 2004 Feb;25(4):342-348.
Acharya YT (ed.). Commentary Ayurveda Dipika of Chakrapanidatta on Charaka Samhita of Agnivesha, Sutra Sthana; Kiyantahshirasiya adhyaya: Chapter no-17, Verse no-78-81. Chaukhamba Sanskrit Samsthana; Varanasi; 2001.
Acharya YT (ed.). Commentary Ayurveda Dipika of Chakrapanidatta on Charaka Samhita of Agnivesha, Chikitsa Sthana; Prameha Chikitsa adhyaya: Chapter no-6, Verse no-40. Chaukhamba Sanskrit Samsthana; Varanasi; 2001. p. 240.
Sarangadhara. Sarangadharsamhita Hindi Translation by Parsuram Vidyasagar Shastri, Madhyamkhanda, Chapter no-6, Verse no-140-143. Varanasi: Choukhambha Prakhashana; 1983. p. 194.